depression major depressive disorder
Conditions
Interventions
None listed
Sponsors
Academisch Ziekenhuis Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: chronis hepatitis infection eligible for IFNa treatment
Exclusion criteria
Exclusion criteria: - age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study parameter: association between the changes in DNA methylation of certain genes in blood lymphocytes and the severity of depressive symptoms during IFNa treatment. Endpoint 8 weeks after cessation of IFNa treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| no | — |
Countries
Netherlands
Outcome results
None listed